Waldron Private Wealth’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,522
Closed -$457K 350
2024
Q4
$457K Sell
1,522
-159
-9% -$55.6K 0.02% 262
2024
Q3
$683K Buy
1,681
+29
+2% +$10.6K 0.03% 211
2024
Q2
$531K Sell
1,652
-216
-12% -$70.2K 0.02% 226
2024
Q1
$624K Buy
1,868
+2
+0.1% +$611 0.03% 208
2023
Q4
$505K Sell
1,866
-174
-9% -$43K 0.02% 232
2023
Q3
$502K Buy
2,040
+781
+62% +$214K 0.03% 229
2023
Q2
$382K Sell
1,259
-29
-2% -$8.06K 0.02% 261
2023
Q1
$340K Buy
+1,288
New +$327K 0.02% 308
2022
Q2
Sell
-979
Closed -$245K 394
2022
Q1
$245K Buy
979
+90
+10% +$22.6K 0.01% 354
2021
Q4
$228K Hold
889
0.01% 348
2021
Q3
$215K Buy
+889
New +$217K 0.01% 335

Other funds holding HCA

Waldron Private Wealth's HCA Position: Q1 2025 in Review

Waldron Private Wealth sold out of HCA Healthcare (HCA) in Q1 2025, closing a stake of 1,522 shares — an estimated $457K sold.

Waldron Private Wealth first reported a position in HCA in Q3 2021 and held it in 11 quarters. The position peaked at $683K in Q3 2024. 1,224 funds tracked by Wall St. Rank hold HCA as of Q1 2025.

  • Waldron Private Wealth reported no remaining HCA Healthcare position as of Q1 2025 after selling out during the quarter.
  • Waldron Private Wealth sold 1,522 HCA Healthcare shares in Q1 2025, an estimated $457K.
  • Waldron Private Wealth first reported a position in HCA Healthcare in Q3 2021 and held it in 11 quarters.
  • Waldron Private Wealth's HCA Healthcare position peaked at $683K in Q3 2024.
  • 1,224 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2025.

Based on Waldron Private Wealth's 13F filing for Q1 2025, filed 8 May 2025.